









Rather than ‘superbugs’ signifying recalcitrant forms of life that withstand biomedical
treatment, drug resistant infections emerge within and are intricate with the exercise
of social and medical power. The distinction is important, as it provides a means to
understand and critique current methods employed to confront the threat of wide-
spread antimicrobial resistance. A global health regime that seeks to extend social
and medical power, through technical and market integration, risks reproducing a
form of triumphalism and exceptionalism that resistance itself should have us
pause to question. An alternative approach, based on a postcolonial as well as a
‘post-colony’ approach to health and microbes, provides impetus to challenge the
assumptions and norms of global health. It highlights the potential contribution that
vernacular approaches to human and animal health can play in altering the milieu of
resistance.
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Where there is power, there is resistance, and yet, or rather conse-
quently, this resistance is never in a position of exteriority in rela-
tion to power. (Foucault, 1990: 95–6)
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On Resistance
Resistance, whether understood as counter-repressive opposition to a
dominant order or as agonistic process inherent to the exercise of
power, is normally associated with intentional and emergent political
acts (Hughes, 2019; Sharp et al., 2000; Foucault, 1990; Lilja and
Vinthagen, 2018; Scott, 1985; Featherstone, 2008). This predominantly
social reading of power and resistance has been under sustained challenge
for some time. Foucault was of course insistent on the role of discursive
practices, and the ‘disposition of things’ (Foucault, 2007: 99), within any
process of governing. His mobilization of the term ‘milieu’ to mark an
intersection of a multiplicity of individuals (or entities) ‘in a set of mater-
ial elements that act on them and on which they act in turn’ (Foucault,
2007: 22, emphasis added) identified agential power as a more-than-
human matter (see also Lemke, 2015: 10). The argument is well-made
across the social sciences, from Feminist Science Studies (Haraway, 1985;
Barad, 2007) to Philosophy (Stengers, 1997; Mol, 2002), Science and
Technology Studies (STS) (Law, 1991; Latour, 1993), Geography
(Braun and Whatmore, 2010), Anthropology (Kirksey and Helmreich,
2010) and Political Sciences (Bennett, 2010). To gloss things too briefly,
ordering and resistance become a more or less agonistic dance of agency
(Pickering, 2008), where systematic distinctions between human and
other-than-human worlds continuously fail (Lemke, 2015).
This associational and other-than-human register is perhaps no more
apparent than in the now frequent use of resistance to signal a swath of
increasingly prevalent forms of untreatable infections and diseases. Drug
resistant infections most often refer to the ability of pathogenic microbes
and protozoa to bypass the pharmaceutical therapies that have been
manufactured and used (often liberally) as a means to reduce their effect-
ivity. Specifically, and while not a new phenomenon, the rise of antibiotic
and antimicrobial resistance1 has prompted increasing concern over the
last few decades. Widespread drug resistance threatens to undermine
health care practices and return societies, some argue, to a pre-modern
age, or propel them into a post-antibiotic future (Davies, 2013; Brown
and Nettleton, 2017).
This surfeit of microbial resistance is perhaps testimony to a form of
material recalcitrance, or even ‘thing power’ (Bennett, 2010). Resistance
here might figure as that which frustrates medical power – with recalci-
trance a matter of microbiological steadfastness combined with inappro-
priate or ‘irrational’ medicine use. The figure of the oppositional ‘super
bug’ coupled to the poorly disciplined clinical setting, unregulated
pharmaceutical industry, weak infrastructure, and/or a rapacious and
unruly food production sector are frequent bêtes noires in this tale of
material mis-behaviour and mis-management (Laxminarayan et al.,
2013; Podolsky, 2014; Santesmases, 2018; Nerlich and James, 2008).
2 Theory, Culture & Society 0(0)
Resistance is, in that sense, a matter to be overcome (with improved
pharmaceuticals, greater awareness and behavioural change as means
to manage the social-microbiological interface). Indeed, these mobiliza-
tions of resistance, which imply matters to be extrinsic to medical order,
suggest a narrative of mastery and eventual control; there is a tone of
‘we’re not quite there yet’ as innovation and improved governance seek
to tame more and more of their social and material environs.
Another possibility, and perhaps more in keeping with the material
politics that Foucault and others started to trace, is to refuse to see
microbial resistance as extrinsic to any exercise of power. Rather,
untreatable conditions are products of their milieu. Resistance is not a
steadfastness, temporary or otherwise, in the face of the imposition of a
norm, but part and parcel of a play of forces. In this vein, resistance is
integral with social power, and can constitute an event that ushers in new
possibilities, and new modes of normativity (Canguilhem, 1991 [1966]). It
has a ‘virtual power’ which may give us pause for thought (Stengers,
2005: 185), and so provide an opportunity to think again about microbes,
social being and normative categories of health and disease. In this regis-
ter, there is a need to avoid a form of materialism or vitalism that too
quickly abstracts living matters from their histories (Landecker, 2016;
Latour, 1999) and geographies. As Braun and Whatmore (2010: xxix)
suggest, contra vitalism, there is a need to pay close ‘attention to the
specificity of the matter at hand’, its relationships and responses to exer-
cises of power, rather than to invoke a generic analogy to ‘life’, liveliness
or thing power. This may be more than a matter for conceptual clarity.
For to invoke a metaphysics of matter also tends to imply a unified
response to that matter, when the ‘matter at hand’, or the milieu of
resistance, may provide some rather different lessons in terms of how
best to respond.
In the terms of this paper, the question is, how can the socio-material
milieu of drug resistant infections provide impetus to the current pre-
dicament? Specifically, and baldly, the paper argues that the tendency to
treat drug resistance as material and social recalcitrance, and to assume
that its very singularity provides the basis for a unified approach to the
problem, irrespective of milieu, health practices or ecologies, risks repro-
ducing a form of human exceptionalism that resistance itself should have
us pause to question. In particular, the yoking of resistance to a current
moment in global health results, I argue, in a peculiarly impoverished
approach to resistance. In contrast, and as Foucault’s knotty account of
resistance has it, one is often ‘dealing with mobile and transitory points
of resistance, producing cleavages in a society that shift about, fracturing
unities and effecting re-groupings [. . .] the swarm of points of resistance
traverses social stratifications and individual unities. And it is doubtless
the strategic codification of these points of resistance that makes a revo-
lution possible’ (Foucault, 1990: 96). To miss the swarm of points of
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(antimicrobial) resistance, and to quickly invoke a unity, undermines the
radical potential for a politics of more-than-human resistance.
In order to develop this argument, I take a number of slices through
the resistance predicament. First, I trace the ways in which the issue has
been formatted as an international issue. Second, I characterize its prob-
lematization as a particular instantiation of postcolonial global health,
and third, I outline a brief history of ‘post-colony’ microbes. I finish with
cases from health care and food production as a means to illustrate where
a reanimated resistance politics, alive to social and microbial difference,
might take us.
On Antimicrobial Resistance
Antimicrobial resistance, or the ability of microbial life (including bac-
teria, viruses, archaea, fungi and protozoa) to persist in the presence of
the medicines and other chemicals that have been developed and used to
control them, is a global challenge with threats to universal health cover-
age and sustainable food supplies. In terms of impacts, drug resistant
infections are, and will be, particularly devastating to already vulnerable
populations, with people in low-income countries severely affected by
increases in disease incidence, reduced food production and, in addition
to current shortfalls in medicine availability, a lack of reliably effective
treatments (Ahmed et al., 2018; Årdal et al., 2016). As the worldwide
total of extremely poor people is predicted to treble by 2030 (a figure that
is likely to be a gross underestimate after COVID-19), limited access to
available and effective medicines will be even more serious in those com-
munities which are already under severe socio-economic stress (Goutard
et al., 2017; Roope et al., 2019; World Bank, 2017). Widespread drug
resistance will also be life-limiting to those people who are immuno-
compromised and may render previously routine or minor medical con-
ditions untreatable (Smith and Coast, 2013). Beyond human health,
resistance will impact on food systems (Grace, 2015) and, combined
with other security challenges, will undermine global and national
resilience.
This crisis-in-the-making and emergency-to-come is commonly attrib-
uted to the mid-20th-century expansion of antimicrobial treatments
(Landecker, 2016; Kirchhelle, 2020; Klein et al., 2018), as well as to
the stalling of relevant research and development from the 1970s
onwards (itself the result of market failures, mergers, acquisitions and
privatizations, and slow bench-to-bedside processes) (Payne et al., 2007).
Inappropriate and avoidable use of antibiotics and antimicrobial com-
pounds as well as transmission of resistant organisms to and from
people, livestock and the environment has altered somatic as well as
environmental microbial selection processes and pressures (Wellington
et al., 2013; Holmes et al., 2016; Bengtsson-Palme et al., 2018; Caudell
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et al., 2018). The emergence, persistence and transmission of resistant
strains of bacteria and mobile resistance-conferring genes over several
decades are arguably key indicators of Anthropocene-era changes to
planetary biology (Landecker, 2016; Gillings, 2017). As Landecker
phrases it, ‘the bacteria of today are not the bacteria of yesterday [. . .]
[having] different plasmids and traits and interrelations and capacities
and distributions and temporalities than bacteria before modern anti-
biotics’ (Landecker, 2016: 21).
Similar in manner to the international policy-framings of climate
change (Wynne, 2010; Yusoff and Gabrys, 2011; Lee and Motzkau,
2013), action on resistance is underpinned by a narrative of an unregu-
lated past and a profligate present, both of which seed an apocalyptic
future (Brown and Nettleton, 2017). In response, a dire prophecy is
drawn into the present, with calls for immediate action to avert worst-
case scenarios. The temporal and ‘balance sheet’ disjuncture between
immediate benefits and deferred public costs partly explains the difficul-
ties in generating collective action for the emergency-to-come. A domin-
ant framing of the issue has focused on the problem of ‘irrational’
resource or medicine use, the need for greater public awareness of the
consequences of that use and subsequent behavioural change. Improving
prescription practices in health care settings through antibiotic steward-
ship schemes, and altering patient expectations and medicine use through
public information and awareness campaigns, have become key object-
ives of international and national policy prescriptions (Charani and
Holmes, 2019; Will, 2019). Within agriculture, which accounts for well
over half of global antibiotic consumption (and a raft of other antimicro-
bial compound uses) (Van Boeckel et al., 2015), there has been a similar
focus on reducing veterinary prescriptions of antibiotics and on educat-
ing farmers in the appropriate applications of antimicrobials and alter-
natives (Laxminarayan et al., 2013). This focus on awareness, behaviour
change and choice (Shove, 2010) has attracted broad social science cri-
tique, neglecting as it does the social, cultural and material drivers of
health and illness, the social and cultural meanings and practices that
relate to medicines, and the economic margins and pressures that relate
to health care provision and food production (Chandler et al., 2016;
Hinchliffe et al., 2018; Broom et al., 2020).
In terms of its spatiality, drug resistance constitutes a global threat
with a distinctly uneven distribution of causes, vulnerabilities and
responsibilities. If the historical gestation of the issue had its focal
point in the Global North, current concerns around growth in antimicro-
bial production, need and use focus on the Global South. While regula-
tory actions may be starting to generate positive signals in many higher
income countries (though see Broom et al., 2020, on the limitations to
stewardship), a concern is often expressed that relatively weak regulatory
environments, poor surveillance, low levels of compliance, higher
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microbial and disease burdens, insufficient medical or veterinary over-
sight and poor value chain governance make the resistance situation less
tractable within lower and middle-income countries (Collignon et al.,
2018; World Health Organisation, 2015). The current focus on lower
income settings is partly driven by what Lakoff (2010) has labelled a
global health regime of ‘humanitarian biomedicine’ but is also under-
pinned by a concern for ‘global health security’. For the latter, the mobi-
lizing logic is one of the emergence and global dissemination of resistant
pathogens, genes and resistance-conferring mobile genetic elements. The
transmission of New Delhi metallo-beta-lactamases from India to north-
west Europe in the mid-2000s (Yong et al., 2009) and the widespread
prevalence of mobile genetic elements associated with resistance to the
last-line antibiotic Colistin (Liu et al., 2016) underpinned this security
logic. As lower income settings became the focus for concern, so the
familiar trope of modernization of backyard farms, backward clinics,
scientific capacity and regulatory governance became key sites for con-
sternation, investment and change (Braun, 2007; Shukin, 2009).
The focus on inappropriate behaviour, modern health and food infra-
structure, as well as the figuring of an uneven though connected world of
shared threats shaped a policy process wherein strategic international
goals were agreed and then cascaded through a system of national
action committees. In 2015, a Global Action Plan was endorsed at the
68th World Health Assembly, with signatories ‘urged’ to develop
national action plans by 2017 (World Health Organisation, 2015). The
global plan included five strategic objectives: to improve awareness and
behaviour change; to develop surveillance of antimicrobial uses and
resistance; to improve infection prevention and control; to optimize use
of medicines; and to increase sustainable investment in combating resist-
ance. Objective 1 of the global plan, for example, stipulated that action
was required to ‘promote behavioural change, through public communi-
cation programmes that target different audiences in human health,
animal health and agricultural practices as well as consumers’ (World
Health Organisation, 2015: 8).
A manual for drafting national action plans followed, with multisec-
toral committees encouraged to develop an ‘incremental approach that
countries can adapt to the specific needs, circumstances and available
resources of each individual country’ (WHO et al., 2016: 1). These cir-
cumstances and differences were largely framed as deficits relative to the
stewardship activities and surveillance capacities in the geographical core
of Euro-American modern health and food production, with compara-
tive insufficiency reinforced by the simultaneous provision of inter-
national and bi-lateral funds that could be used to address shortfalls in
surveillant capacity. The ability to meet global objectives was judged as a
matter of the stage at which a country finds itself: ‘As Member States are
at different stages in combating AMR, there is flexibility in activity
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planning and target setting to meet both local requirements and global
priorities’ (WHO et al., 2016: 5, emphasis added). In the same paragraph,
the link between stage and capacity was underlined: ‘Countries differ in
the availability of coordinating mechanisms, existing legislation, their
laboratory capacity and data on the impact of AMR on society. The
drivers such as use of antimicrobials and the systems and structures
available to prevent and control the emergence and spread of AMR
may also vary. The status of each of these factors will influence decisions
in planning, target-setting and prioritisation’ (WHO et al., 2016: 5).
While flexibility was to be welcomed, it was also the case that framing
of in-country circumstances as comparative lack followed a developmen-
talist agenda (Escobar, 1995). The latter tends to reduce geographical
difference (with all of the material and social-spatial relations of past and
present imperialisms, colonialisms, the exigencies of corporate capital
and extractive relations between core and periphery) to a league table
of relative wealth and technical ‘capacity’. Differences become matters of
temporal delay rather than ongoing spatial production (Massey, 2005)
with little or no consideration of the effects of uneven development and
spatialized impoverishment (Smith, 2008). The roles of structural adjust-
ment and marketization of public services and their impacts upon the
kinds of health care provision, agricultural practices, public spending and
ultimately the relationships between people, environments and microbes
are all effaced. These might include substantial variations in health care
priorities (for example relating to primary health care needs); pressing
issues with antimicrobial medicine supply where access to rather than
excesses of treatments are the key concerns; the varying roles of state
and civil society organizations as agents in the formation and delivery of
health and food-related projects; and alternative trajectories for food
production that do not follow the models of agriculture in the Global
North. As differences are reduced to matters of relative capacity, these
and other alternative modes of being or practice, which may offer key
insights in terms of structural drivers of resistance, as well openings on to
other kinds of development, become notable through their absence. In
short, there is an implicit assumption that cultural and economic differ-
ences are obstacles to rational or good behaviour. Culture is a label that
tends to be used as a synonym for inappropriate or incorrect (non-scien-
tific) knowledge, and or misinformed beliefs, habits and practices
(Ledingham et al., 2019). Similarly, economy tends to be understood
as signifying levels of underdevelopment in terms of human health care
provision and backyard/backward or poorly organized food production
systems. In turn, the possible advantages or affordances of health cul-
tures and agricultures that are not easily aligned to the conveyor belt of
one-dimensional development are rarely acknowledged.
The idea that differences, cultural and otherwise, may act as assets,
opportunities or openings onto new ways of framing and approaching
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drug resistance was not countenanced in these publications. This omis-
sion, one could argue, was a missed opportunity but also ran the risk of
normalizing the very conditions that can act as drivers of antimicrobial
uses and resistance. In order to develop these points, there is need, first,
to situate antimicrobial resistance policy within a marketized and inte-
grative approach to global health and, second, to introduce a process-
based or post-colony approach to ‘resistant microbes’.
On Postcolonial Global Health
In a landmark review of global health, Nicholas King underlined the
semantic and material links between global health and ‘American anxi-
eties about living in a globalised world’ (King, 2002: 764). Writing at a
time marked by heightened fears of bio-terror as well as pathogens of
pandemic potential, King summarized a shift in international and global
health from a colonial concern with non-western beliefs and practices, or
epistemic difference, to a postcolonial one of economic and ontological
integration. Less concerned with indigenous medical beliefs, a civilizing
mission, or colonial governance, the triumphal and exceptionalist narra-
tives of scientific and technological superiority and economic expansion-
ism were instead increasingly linked to provision of and trade in health
technologies and services. So, for example, in a report entitled America’s
Vital Interest in Global Health: Protecting Our People, Enhancing Our
Economy, and Advancing Our National Interests, the links were made
explicit: ‘America must engage in the fight for global health from its
strongest basis: its pre-eminence in science and technology. US expertise
in science and technology and its strength in biomedical, clinical, and
health services research and development are the engine that has helped
power many of the advances in human health and well-being of this
century’ (Institute of Medicine, 1997: v–vi). For King, there was a con-
sequent shift in the geopolitics and geographies of international health
from a colonial tendency to establish sanitary micro-territories, or a
home from home within colonial ‘outposts’, to a more diffuse, less terri-
torial, network that facilitated the circulation of biomedical information
and technique. The contained spaces of the micro-colony or disease-free
cordon sanitaire were displaced by a utopian biomedical macro-colony
wherein health became an opportunity for market expansion. This sup-
planting of containment by a network of health markets was driven by a
new spatial horror: ‘not the horror of matter (or bodies) out of place,
which presupposed the identification of a place for matter; instead, it is
the horror of places no longer mattering, of a ‘‘third-worlding’’ at home’
(King, 2002: 773). In other words, a bio-communicable world became
simultaneously a homeland security threat and a market opportunity
within an emergent ‘disaster capitalism’ (Cooper, 2008). Data gathering
and international partnerships became key modes of operation, with
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disease control ‘achieved through worldwide consumption of biomedical
technology’ (King, 2002: 776).
For King, this age of health-as-market-opportunity augured a shift
from a concern with epistemological differences and knowledge diffusion
to a focus on efficiently managing global circulations of medical (and
agricultural) services and products in a ‘smooth terrain of global capit-
alist exchange’ (King, 2002: 779). Global health was thus made condi-
tional upon an export model of embodied knowledges and products to
farmyards and clinics across the world. The resulting absence of ques-
tions of culture and belief systems within global public health suggested
‘that the conflict between ‘‘Western’’ and ‘‘traditional’’ health systems is
either over (with the former as victor), or is wholly irrelevant’ (King,
2002: 782), with battles over cultural difference now displaced by ‘dis-
agreements over the relative place of stakeholders in global exchange
networks’ (King, 2002: 779). If colonial health was a system of epistemo-
logical conversion, its postcolonial successor was a matter of ontological
integration. ‘Local populations present obstacles not because of incom-
mensurate belief systems or cultural differences, but because of incom-
plete integration into the modern projects of total surveillance and
seamless exchange’ (King, 2002: 782).
This account of global health integration is useful, though it is worth
noting that the ‘irrelevance’ of incommensurable health knowledges has
turned out to be slightly wide of the mark. First, while knowledge may no
longer be a key tool of empire, markets in biomedical products and
clinical as well as technical approaches to health and agriculture never-
theless involve shifting economies, practices and cultures, and, in so
doing, arguably produce new colonial spaces of the ill-equipped and
the ill-informed. Perhaps as a mirror to Anderson and Adams’ ‘Marie
Celeste’ version of colonial science (Anderson and Adams, 2008),
whereby scientific and technological knowledge was exported without
due recognition of the role of commerce as its key mode of dispersal,
King’s account suggests that it is now commerce that stands centre stage,
while knowledge and science become the empty vessels through which
this smooth terrain is enacted. In this sense, the image of a friction-free
export model of global health technique may be somewhat deceptive.
Rather, global health continues to enframe and capture recipient coun-
tries within western norms (Brown and Bell, 2008). Second, the popular-
ity of social media platforms, the rise of health mis-information
(especially, but not only, concerning vaccination) (Vraga and Bode,
2020), the role of ‘fake’ or counterfeit medicines and fake-in-the-real
hybrids (Kingori and Gerrets, 2019) as well as a policy-based tendency
to prioritize awareness and behaviour change, mean that non-biomedi-
cally mainstream knowledge continues to be framed as a persistent prob-
lem for global health. Third, in the particular case of antimicrobial
resistance, the dominant discourse has not simply been the need to sell
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more product but also to regulate sales and medicine use. The result has
been a simultaneous need to align markets as well as to change beliefs
and raise biomedical awareness. So, contra King, knowledge and beliefs
have retained their relevance to global health and continue to be treated
as matters for correction. In this, the spaces of the ill-equipped are sim-
ultaneously populated by those considered to be ill-informed. But before
returning to the implications of this formatting of antimicrobial resist-
ance as a matter for networking of technique and beliefs, there is a need
to engage with post-colony microbes.
On Postcolonial Microbes
Colonies are equally prevalent in ecological and biological thinking as
they are in imperial and economic imaginations. Within biology more
generally the metaphor of the colony is firmly linked to hierarchical cat-
egorizations of organization (cell, organisms, social group, colony) and
inextricably bound to a species-centred imagination wherein a self-iden-
tical grouping occupies a space-time (Taylor and Dewsbury, 2018).
Within microbiology, a colony tends to refer to a visible mass of organ-
isms that are derived from the same ‘mother’ cell. These colonies were
key to the science of bacteriology, with the ability to isolate and culture a
bacterium and to test a resulting clonal population’s susceptibility to
various antimicrobial treatments a mainstay of drug development and
resistance surveillance. Indeed, the derivation of minimum inhibition
concentrations and standard breakpoint assays on plated cultures
became key tools in the framing of what counts as resistant microbes.
Koch’s postulates of a self-same population of bacterial ‘species’ under-
pinned a methodology of isolation, reproduction and vertical inheritance
of traits (Gradmann, 2009). Bacteria were, as a result, effectively fixed in
their identities, with any variance explained through random mutations
and vertically inheritable traits.
Explanations of antimicrobial or more specifically antibiotic resistance
were initially based on this methodologically-driven clonal model. At low
or poorly calibrated doses it was assumed that antibiotics would select
for those strains within a bacterial colony that had developed the neces-
sary cell wall or other cellular equipment to reduce or negate the effects
of the treatment. As historians of medicine emphasize, the assumed evo-
lutionary mechanism, and the likelihood that sub-lethal doses would lead
to selection for resistance, spurred clinical researchers to advise long and
high dose rates, and the development and prescription of a range of
antibiotics which, when used in combination or sequence, would guard
against the re-colonization of a patient with resistant strains (Podolsky,
2014; Bud, 2007). In the US, this model underpinned a commercial and
regulatory battle to develop, market and approve a range of antibiotics
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and fixed dose combinations, and in turn prompted new norms for clin-
ical evidence-making (Podolsky, 2014).
The scientific basis for this account of both resistance and its thera-
peutic significance was rooted in the modern synthesis of Darwinian
evolution and Mendelian genetics. Yet the primacy of this model of
resistance, based on an understanding of self-identical clonal colonies
of bacteria, was itself under threat just as the modern synthesis had
gained ascendency. Biochemists like Marjorie Stephenson raised the
question in 1934 that perhaps ‘bacteria may tentatively be regarded as
biochemical experimenters’ (cited in O’Malley, 2018: 327), while later
work in molecular biology, including within teams led by Tsutomu
Watanabe, Joshua Lederberg and others, challenged assumptions con-
cerning bacterial identity and asexual or clonal reproduction in bacterial
populations (Lederberg, 2000; Furuya and Lowy, 2006). As Creager
(2007) tells it, these debates over microbiological departures from the
modern synthesis were framed within disciplinary- as well as Cold
War-fuelled contests over Lamarckian adaptation and neo-Darwinian
inheritance, the Lysenko affair and the unexplained rise of multiple
drug resistance in single strains. Yet, from the 1950s onwards, there
was a disciplinary, if not clinical or pharmaceutical, shift from the
micro-colonies of plated, self-same ‘species’, related and organized
through vertical inheritance of genes, to a networked, post-clonal imagin-
ary of diverse communities where differences could be shared horizon-
tally, often within as well as between different microbiological ‘species’.
The work of Watanabe and colleagues had demonstrated, for example,
that resistance could be conferred by ‘cytoplasmic resistance factors’ and
disseminated through diverse bacterial populations without changes to
the chromosome. This ‘infective hereditary’ (Watanabe, 1963) involved
the mobilization of genetic material between and within bacterial popu-
lations. In some ways foreshadowing the development of the post-
genomic era and systems biology (Guttinger and Dupré, 2016), and the
approaches made possible through metagenomics, this post-colony
approach involved a move away from ‘a focus on single organisms or
monogenomic species’ (Guttinger and Dupré, 2016: np). In its place,
resistance becomes a relational process, generated, persisting and trans-
mitting within and between ‘species’ as a ‘communal resource’ (McFall-
Ngai et al., 2013). Mobile genetic elements enable resistance to be shared
widely and conserved within a microbiological community, a sharing that
can offset inhibitory fitness costs and allow resistance to persist even
without the necessity of continued selection pressure from the addition
of antimicrobial treatments (Melnyk et al., 2015; Chow et al., 2021).
This post-colony sensibility informed what Wright (2007) designated
as a global ‘resistome’, a term used for the collection of all the antibiotic
resistance genes (in pathogens as well as commensal microbes) that exist,
and which could act as a reservoir of genes that may be expressed and
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transmitted. For Wright, and later Gillings (2017), the resistome is
ancient, provides stores of resistance capabilities and has undergone sub-
stantial recent historical change. The pan-global resistome arguably gives
substance to the early 20th-century biogeographical precept, or Baas-
Becking principle, that ‘everything is everywhere, it’s the environment
that selects’ (O’Malley, 2008). In other words, if Landecker (2016) used
infectious hereditary to emphasize the biology of history, then post-
colony microbes augment history and start to open up the importance
of treating resistance as a matter of geography. Doing so starts to trace a
socio-biome wherein resistance is not simply a matter of microbial recal-
citrance or social misconduct, but the agentic dance of socio-environ-
mental processes.
On Doing Resistance Otherwise
At the outset of this paper I suggested that the tendency to treat drug
resistance as material and social recalcitrance, and to assume that its very
singularity provides the basis for a unified approach to the antimicrobial
resistance problem, irrespective of milieu, health practices or ecologies,
risks reproducing a form of human exceptionalism and triumphalism
that resistance itself should have us pause to question. The issue has
been framed as a global health problem, the solution to which is to
emphasize commercial and scientific integration rather than confronting
uneven spatial processes of modernization. I have also raised the trou-
bling figure of the resistome to emphasize that resistance is more than
recalcitrance; it is a networked play of social and microbiological pro-
cesses that undermines any straightforward reduction to a single causal
driver. The liveliness of micro-organisms is therefore not a metaphysical
property but something that has evolved within a milieu of human
attempts at mastery. Similarly, resistance and the resistome relate to
but are not determined by antimicrobial consumption. And yet, as we
have seen, the tendency in global and national action plans is for inte-
gration of health and food production systems as a means to modernize
and monitor medicine uses. The targets of opportunity (Weber, 2005) are
the spaces of the ill-equipped (and the ill-informed), with a narrative of
western modernism, scientific and technical integration and smooth
exchange as the means through which resistance will be tamed. That
formulation, it should be noted, has tended to downplay the potentials
of infective hereditary or the networked aspects of the resistome – the
ecological milieu or play of microbial inter-activity that give resistance a
situated quality. The result is that we may have ended up with the wrong
networks (economic and technical integration) fighting the wrong kinds
of network (Thacker, 2005).
The preoccupation of global antimicrobial resistance policy with sur-
veillance and behavioural correction in order to combat resistance
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reproduces a logic of global health security, and in so doing has pursued
a model of socio-economic network extension, with modern farming
techniques, health care behaviours and data surveillance, key elements
of integration. This extensionist model tends to assume a smooth oper-
ating surface, paying little attention to spatial difference, the intensities
and the accompanying norms and conditions that are involved in any
power play (Allen, 2011, 2016). In this final section I want to draw
together the postcolonial global health critique of the approach to resist-
ance with a post-colony sensibility to resistance in order to sketch out
how and in what ways the issue may ‘force thought’ and challenge rather
than re-inscribe normative categories of modern practice. I do so through
a few brief cases. The cases are drawn from the author’s own experience
on projects and from discussion with colleagues. They are in that sense
indicative rather than representative.
Sustainably enhancing food production in South and South East Asia
faces a range of challenges (Goutard et al., 2017; Coker et al., 2011;
Godfray et al., 2010). In addition to increased and increasingly complex
demands from growing populations, competition for resources and land,
and uneven trade relations, there are climate stresses and sizable disease
burdens. As farmers attempt to enhance production in conditions where
bacteria can thrive, lack of access to antimicrobial treatments or to alter-
natives can be devastating to plant and animal health and to livelihoods.
Under the terms of national action plans, and conditioned by earlier
attempts to control emerging diseases, the predominant approach to vet-
erinary and livestock uses of antimicrobials has been to seek to modern-
ize production, reduce disease burden and so stem growth in
antimicrobial uses. Biosecurity is one of the key terms in this disease
control narrative. Replacing backyard and small-scale farms with mod-
ernized livestock operations where disease and inputs can be controlled
under veterinary supervision, or reducing the disease exposures of small
farms, have become key aims of global ‘One Health’ agriculture
(Hinchliffe, 2015). However, this paradigm of disease-free farming,
based on integration and seamless economic exchange in accordance
with phyto-sanitary regulations, can prove untenable and even contra-
dictory in some settings. Within poultry farming for example, replacing
small holder and backyard farms with industrialized biosecure indoor
farms is not only socio-economically destructive (Hinchliffe and
Bingham, 2008), ineffective and even sometimes counter-productive in
terms of disease control (Wallace et al., 2015; Dixon, 2015); it may
also be increasingly inappropriate under conditions of climate-related
environmental stress. Cole and Desphande (2019) argue that farmers
around Bangalore, India, have often been forced by water stress and
crop disease out of arable production and into poultry meat production,
and, with little expertise in animal husbandry, they tend to use antibiotics
to manage an array of animal health problems for non-native breeds in
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often crowded and non-biosecure farms. One solution to this disease
burden is to encourage indoor biosecure production. However, the cap-
ital, carbon and running costs (including temperature control) are
beyond the vast majority of producers, and those that adopt indoor
farming methods can inadvertently increase animal stress and reduce
health with inappropriately selected breeds suffering in poorly ventilated
buildings. Modernization under increasing climate stress can in this case
produce the conditions for poorer animal health outcomes and, as a
result, increased pressure to utilize antibiotics.
In Bangladesh there is a similar problem with ‘missing middle’ farms
(commercial farms that are partially integrated into global markets but
who have not benefited from investments in biosecurity or disease con-
trols) (Belton et al., 2018), and who are part of the ‘invisible cohort’ of
farmers who nevertheless account for the majority of food production
worldwide (Kakkar et al., 2018). Within the economically important
shrimp aquaculture sector (second only to finished textile goods in
terms of Bangladesh’s export earnings) there are efforts to reduce disease
burden by making disease-free seed available to farms. Farmers have
tended, in the past, to manage their ponds through continual adjustment
to monsoon rains and other environmental variations by introducing
more stock or species as temperature and salinity conditions vary.
Partly in response to disease and other threats, farmers have stocked a
variety of species and, where possible, used the same gher (embanked
field or pond) to grow paddy rice as well as develop aquaculture. The
result of this polyculture was reasonably reliable productivity and regular
income over an entire growing season, even if the method was far from
being best practice in terms of biosecurity. The NGOs and hatcheries that
were funded internationally to encourage farmers to utilize the disease-
free shrimp seed (or larvae) encouraged farmers to stock only once in a
production period and avoid stocking with a variety of species in order to
reduce disease incursion and animal stress. The result was a reduction in
disease incidence, but a simultaneous increase in the consequences or
stakes of any disease event. Diseases that were once tolerated and
adjusted for with additional stock or other crops now constituted a
threat not just of diminished livelihood but outright loss. As the dis-
ease-free technology and attendant practices were adopted and as farm-
ers relinquished their vernacular forms of livelihood insurance and
adaptation to disease threats, their economic precarity, itself related to
the salvage accumulation (Tsing, 2015) process that best describes the
farmers’ partial integration into global value chains, tended to increase
rather than decrease. Moreover, as antibiotic uses were described by
farmers as attempts to rescue vulnerable stock and seen as a desperate
measure to save livelihoods, the result of adopting disease-free seed was
paradoxically associated with a tendency to increase rather than reduce
reliance on disease treatments (Hinchliffe et al., 2018).
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An alternative strategy is to work with farmers who have managed to
develop an agro-ecological and arguably more resilient approach to
farming in the face of disease and other challenges. In this case, seeing
the farmers’ stocking and harvesting practices as potential assets on
which to build, rather than as barriers to modern production, may
offer more opportunities for doing things otherwise. Conversely, viewing
incomplete economic and phyto-sanitary integration as the main prob-
lem can serve to extend the conditions of production that encourage
greater reliance on antimicrobial treatments. In these cases, economic
divergence rather than convergence may offer resources for rethinking
resistance threats.
In human health settings, the focus on awareness and behaviour has
re-booted concerns around misplaced understandings of health and dis-
ease (the spaces of the ill-informed). For example, in many parts of Asia,
affective bodily registers of heat and inflammation drive treatment-seek-
ing practices. In busy primary health care settings in rural China, treat-
ments are directed towards bodily responses rather than to infecting
pathogens, and antibiotics are popularly known as ‘anti-inflammatory
medicines’ (Lambert et al., 2019). From a stewardship, ‘rational use’ or
public awareness angle, this would seem to be a misconception and based
upon biomedically unorthodox understanding. But as Lambert and col-
leagues insist, to disqualify this knowledge would be to miss the ways in
which health and disease are always mediated through sensory experi-
ence. Discounting experiential aspects of health and illness not only pur-
sues a familiar and ill-fated deficit model of public health but may also
miss the opportunity to work with vernacular accounts of health and
illness as potential springboards for doing things otherwise. If Chinese,
and presumably all, medicine has always been ‘syncretic’ (Law and Lin,
2017), or a hybrid gathering of knowledges and their partial associations,
then it may be that these collectives of bodies and knowledges offer cul-
tural resources for other kinds of practice. Without adopting a romanti-
cized sense of Traditional Chinese Medicine, and not to underplay
current pressures to prescribe antibiotics within the Chinese health care
and insurance systems, working with vernacular notions of health may
nevertheless open up the possibility for re-configuring health and illness
as environmental, social and personal and subject to alteration through a
course of illness (Zhan, 2014). As was the case for the Bangladeshi farm-
ers, it may be the mix of modernisms and health approaches, rather than
their wholesale replacement, which offers more practical as well as cre-
ative approaches to doing resistance otherwise.
Finally, social and environmental drivers of resistance can be as, if not
more, important than antimicrobial uses, especially where transmission
of resistance to and from commensal as well as pathogenic bacteria is
enhanced. In Bangladesh, shrimp farmers have modelled potential resist-
ance drivers in their environment, and highlighted how shortage of
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capital, river waters and hatchery bought seed can all increase resistance
risks in their gher (Hinchliffe et al., 2018). Linking this work to those
efforts to understand sub-inhibitory resistance mechanisms, or minimum
selective concentrations, which can be up to 230 times lower than min-
imum inhibitory concentrations if the social and ecological conditions
are right, would start to give communities more evidence on which to act
(Chow et al., 2021). In northern Tanzania, the links between systems
biology, epidemiology and cultural practices is starting to take shape.
There, and specifically within pastoralist communities, transmission of
resistant bacteria and resistant genes from livestock to people is related
to drinking raw milk (Caudell et al., 2018). While reducing uses of the
antibiotic oxytetracycline in drought and climate-stressed cattle may be a
long-term aim, the lack of veterinary infrastructure and of available
alternative treatments, as well as the possibility that resistance will persist
beyond any reduction in treatment uses, means that the most effective
intervention is likely to be reducing transmission between cattle and
people. In pastoralist communities this requires working with households
to identify key pathways and acceptable alterations to human-animal
practices. A key issue identified by the participants and researchers was
the drinking of untreated milk, and the need to find a means of pasteur-
izing the milk without boiling (the latter makes the milk less nutritious
and, for the Maasai, unpalatable) (Caudell et al., 2019). It is these kinds
of culturally and ecologically specific findings that are required to address
resistance issues. ‘In low-income and middle income countries, where
communities collectively have an extraordinary diversity of socioeco-
nomic systems that blend western and traditional medical belief systems
and that operate within varying regulatory and health-care environ-
ments’ (Caudell et al., 2018: 490) it is essential to understand the range
of proximate and distal drivers of resistance as well as work with the
grain of cultural and socio-economic conditions. Utilizing key social sci-
ence and cultural tools that include participatory processes and the co-
creation of workable interventions will generate the most effective out-
comes and minimize the effects of unintended outcomes.
Conclusions: Viva la Resistance
In Foucault’s methodological precautions regarding power, he called for
an ascending rather than descending analysis of power. In other words,
rather than start from the centre or the top of a hierarchy and deduce
power by seeing how far down it goes, we should begin with power’s
‘infinitesimal mechanisms, which have their own history, their own tra-
jectory, their own techniques and tactics, and then look at how these
mechanisms of power, which have their solidity and, in a sense, their own
technology, have been and are invested, colonized, used, inflected, trans-
formed, displaced, extended, and so on by increasingly general
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mechanisms and forms of overall domination’ (Foucault, 2004: 30). I
have tried to demonstrate how microbial resistance, itself a subject of
historical and material struggles, has been and is being ‘annexed by
global phenomena’ (2004: 31). In this telling, resistance, microbial and
otherwise, is intrinsic with these mechanisms of power. In refusing a
metaphysical account of microbial liveliness, there is an opening to
uncouple this process of continuing annexation. The latter is performed
through the extension and reach of networks of command and control
that operate under the auspices of a global health matrix that invariably
views social, technical as well as epistemological differences as barriers to
change. Extending a global health network may in this case not only miss
the affordances and assets that allow us to think and do resistance other-
wise, but also risks intensifying the very relations that have fuelled the
global resistome.
None of this is designed to under-estimate the importance of drug
resistance, and ‘viva la resistance’ is not meant as a proclamation of
support for a process that is causing and will undoubtedly cause wide-
spread suffering in the future. The affirmation of resistance is instead
indicative that the post-colony, post-genomic microbe may be a signal
to think again about the assumed norms of global health. The post-
colonial model of seamless exchange targets the spaces of the ill-equipped
and the ill-informed. It is a surveillant architecture that exports science
and technology under the premise of commercial integration while
under-valuing cultural and economic difference (and downplaying the
roles of structural and other forms of inequality). New therapies,
phyto-sanitary exclusion zones and biomedical norms are being annexed
to antimicrobial resistance policy while economic and social vulnerabil-
ities as well as alternative practices and beliefs around health and illness
are side-lined. That resistance ushers in a counter norm, or is an event
that should give pause for thought, requires staying faithful to that event
(Stengers, 2011), and working to affirm the lessons that may accrue from
it, even while we are faced with the spectre of innumerable dangers. Vive
la resistance is then a staying faithful to the event that is the global
resistome. Instead of the war that is anti-biosis, it is to suggest that
alternative practices, and using cultural and social approaches to these




1. Antimicrobial refers to all chemicals and medicines that can kill or inhibit microor-
ganisms (viruses, bacteria, archaea, fungi and protozoa). Antibiotic is a more specific
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